Edition:
United States

Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

85.82USD
22 Jun 2018
Change (% chg)

-- (--)
Prev Close
$85.82
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
737,630
52-wk High
$89.25
52-wk Low
$59.64

Chart for

About

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock)... (more)

Overall

Beta: 0.95
Market Cap(Mil.): $41,525.33
Shares Outstanding(Mil.): 483.87
Dividend: 0.13
Yield (%): 0.59

Financials

  ZTS.N Industry Sector
P/E (TTM): 35.39 29.56 34.14
EPS (TTM): 2.42 -- --
ROI: 17.50 13.56 13.10
ROE: 66.80 15.35 15.09

RPT-Wall St Week Ahead-Healthcare investors weigh bets as election risks loom

NEW YORK, June 1 If 2016 is any guide, pharmaceutical, biotech and other healthcare stocks could be in for a rough summer and fall heading into another round of U.S. elections.

Jun 03 2018

Healthcare investors weigh bets as election risks loom

NEW YORK If 2016 is any guide, pharmaceutical, biotech and other healthcare stocks could be in for a rough summer and fall heading into another round of U.S. elections.

Jun 01 2018

Wall St Week Ahead-Healthcare investors weigh bets as election risks loom

NEW YORK, June 1 If 2016 is any guide, pharmaceutical, biotech and other healthcare stocks could be in for a rough summer and fall heading into another round of U.S. elections.

Jun 01 2018

Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 billion

Top animal health company Zoetis Inc will buy Abaxis Inc for $1.9 billion, looking to capture a bigger slice of the fast-growing market for diagnostics services that cater to household pets and farm animals.

May 16 2018

REFILE-UPDATE 5-Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 bln

* Zoetis says diagnostics should grow faster than animal health

May 16 2018

BRIEF-Abaxis Inc - Upon Termination Of Merger By Co Or Zoetis Upon Specified Conditions, Termination Fee Of $70 Mln May Be Payable By Co To Zoetis

* ABAXIS INC - UPON TERMINATION OF MERGER BY CO OR ZOETIS UPON SPECIFIED CONDITIONS, TERMINATION FEE OF $70 MILLION MAY BE PAYABLE BY CO TO ZOETIS

May 16 2018

BRIEF-Zoetis Says Upon Deal Termination By Abaxis Or Co, Termination Fee Of $70 Mln May Be Payable By Abaxis

* ZOETIS SAYS UPON DEAL TERMINATION BY ABAXIS OR CO, TERMINATION FEE OF $70 MILLION MAY BE PAYABLE BY ABAXIS - SEC FILING Source text: (https://bit.ly/2KprpqL) Further company coverage: (Reuters.Briefs@thomsonreuters.com)

May 16 2018

BRIEF-Zoetis To Acquire Abaxis for about $2 Bln In Aggregate

* ZOETIS TO ACQUIRE ABAXIS, A LEADING GLOBAL PROVIDER OF VETERINARY POINT-OF-CARE DIAGNOSTIC INSTRUMENTS

May 16 2018

Zoetis to buy Abaxis for $1.9 bln in cash

May 16 Animal health company Zoetis Inc said on Wednesday it would buy Abaxis Inc, a maker of veterinary diagnostic instruments, for about $1.9 billion in cash.

May 16 2018

BRIEF-Anatara Lifesciences Announces Exclusive Global License Agreement With Zoetis

* ANNOUNCES EXCLUSIVE GLOBAL LICENSE AGREEMENT WITH ZOETIS Source text for Eikon: Further company coverage:

May 14 2018

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $61.47 --
Bayer AG (BAYGn.DE) €97.56 -1.28
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €69.29 +0.28
Eli Lilly And Co (LLY.N) $85.92 --

Earnings vs. Estimates